Last reviewed · How we verify
Dan-shen extract
At a glance
| Generic name | Dan-shen extract |
|---|---|
| Also known as | salvianolic acid, Depside salt from Salvia Miltiorrhiza, Danshen Dropping Pill, dropping salvia pill |
| Sponsor | Taizhou Fourth People's Hospital |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Outcome Research to Confirm the Anti-anginal Effect of T89 in Patients With Stable Angina (PHASE3)
- Safety and Efficacy of T89 in the Prevention and Treatment of Adults With Acute Mountain Sickness (AMS) (PHASE3)
- Effect of a Dietary Supplement on Lipid Pattern, Indexes of NAFLD and Systemic Inflammation in Healthy Subjects With Suboptimal LDL-C Levels (NA)
- An Intervention Study of Compound Silymarin in Patients With Non-alcoholic Fatty Liver Disease (NA)
- Expanded Access to T89 for Treatment Use in Intermediate-size Patients Population With COVID-19
- Effects of Tablets of Silybum Marianum, Pueraria Lobate and Salvia Miltiorrhiza on Fatty Liver (NA)
- Multi-"Omics" Research of Danhong Injection to Treat Acute Ischemic Stroke (PHASE4)
- Safety and Efficacy of T89 in Prevention and Treatment of Adults With Acute Mountain Sickness (AMS) (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |